This is high blood pressure in the portal vein, which carries blood from the intestines to the liver. The cause is unknown, and it's not caused by liver scarring (cirrhosis) or parasites. It's often related to problems with the blood vessels in the portal system.
Every report comes from a Lived member, sent anonymously.
Have you tried Inderal (Propranolol) for Idiopathic Noncirrhotic Portal Hypertension?
Idiopathic noncirrhotic portal hypertension (INCPH) is a rare liver condition in which pressure builds up in the portal vein, the large vein that carries blood from the intestines and spleen to the liver. In most people with portal hypertension, the cause is cirrhosis, meaning heavy scarring of the liver. In INCPH, the liver is not cirrhotic. Instead, the small branches of the portal vein inside the liver become narrowed or blocked, so blood has trouble getting through. The main problems come from that backed-up blood rather than from a failing liver. Blood is pushed into alternative routes, creating enlarged, fragile veins called varices, most often in the esophagus (the tube between the throat and stomach). Varices can bleed. The spleen also tends to enlarge and trap blood cells, which lowers blood counts. Liver function itself is usually preserved, at least early on, which is one of the clearest differences from cirrhosis. Doctors increasingly place this condition within a newer, broader category called porto-sinusoidal vascular disorder. Older names for the same disorder include noncirrhotic portal fibrosis (used especially in South Asia), idiopathic portal hypertension and Banti's syndrome.
Idiopathic means no single cause has been found, and for many people that remains true. Still, most people with this condition turn out to have at least one associated condition that may play a role, although a direct cause has not been proven for most of them. Roughly one-third have none that can be identified. The associations fall into a few groups. Immune system disorders, such as common variable immunodeficiency (an inherited weakness in antibody production) and some autoimmune diseases, are linked to it. So are conditions that make blood clot too easily, which may cause repeated tiny clots in the small portal veins. Some medicines and toxins are implicated, including thiopurines (immune-suppressing drugs such as azathioprine and thioguanine), the chemotherapy drug oxaliplatin, some HIV medicines, and arsenic. Rare genetic syndromes and HIV infection are also associated. Repeated abdominal infections early in life are thought to contribute in regions where the condition is more common, such as parts of South Asia. As testing improves, more cases once labeled idiopathic are being traced to a specific underlying disorder. Finding one matters because it can change care.
The condition is often discovered when someone has an enlarged spleen, low platelet or blood counts, varices found on endoscopy, or a bleeding episode, yet blood tests of liver function look fairly normal. Because the signs look so much like cirrhosis, people are sometimes first told they have cirrhosis of unknown cause. Ultrasound with Doppler (which shows blood flow) is usually the first imaging test, often followed by CT or MRI to check that the portal and hepatic veins are open and to look for clots. Upper endoscopy, a camera passed through the mouth, looks for varices in the esophagus and stomach. Liver stiffness measurements (elastography, a quick ultrasound-based scan such as FibroScan) tend to be lower than in cirrhosis, but they can overlap and cannot settle the question on their own. A liver biopsy is required. A small, good-quality sample of liver tissue is examined to rule out cirrhosis and to look for characteristic changes in the small portal veins, such as narrowed veins or a nodular pattern of liver cells called nodular regenerative hyperplasia. These changes can be subtle, so review by a pathologist experienced in liver disease helps. The diagnosis also requires ruling out other causes, such as viral hepatitis, schistosomiasis (a parasitic infection), and clots blocking the main liver veins. Under recent international criteria, a definite diagnosis can rest on specific biopsy changes alone, or on subtler biopsy changes combined with clear signs of portal hypertension, such as medium or large varices or a past bleed from varices.
There is no treatment yet that reverses the vein damage itself, so care focuses on preventing and managing complications, especially bleeding from varices. Because liver function is usually good, people often tolerate these treatments better than people with cirrhosis. For varices, the approaches largely follow those used in cirrhosis. Beta-blockers such as propranolol, nadolol or carvedilol lower pressure in the portal system and reduce the chance of bleeding. Band ligation places small rubber bands around varices during endoscopy so they shrink and scar over; it usually takes several sessions. Either approach, or both, may be used, and after a bleed both are often combined to prevent another. Beta-blockers are not suitable for everyone, including some people with asthma or certain heart rhythm problems. Blood thinners (anticoagulants) are not used routinely. They are considered when a clot forms in the portal vein, which happens fairly often over time, and the decision weighs clot risk against bleeding risk from varices. When an associated condition is found, such as a clotting disorder or a medicine linked to the disease, treating or stopping it is part of care. When bleeding keeps returning or fluid builds up despite treatment, a TIPS (transjugular intrahepatic portosystemic shunt) may be placed. This is a stent, inserted through a vein in the neck, that creates a channel to relieve pressure. People with this condition often do better after TIPS than people with cirrhosis, mainly because liver function is preserved, though confusion from blood bypassing the liver can still occur. Removal of the spleen or surgical shunts are options in selected cases. Liver transplantation is reserved for the few people who develop serious complications such as liver failure.
The outlook for the liver is generally better than with cirrhosis. Many people live for years with stable liver function, and with prevention and treatment of varices, death from bleeding is uncommon. Long-term studies show that liver-related deaths are uncommon. Overall survival can still be shortened, mostly by associated illnesses and other conditions of older age, which is why managing those conditions matters. People who develop ascites (fluid in the abdomen) tend to have a less favorable outlook, and some people eventually develop worsening liver function. Day to day, many people feel well. Ongoing care usually involves regular visits with a liver specialist, periodic blood counts, repeat endoscopies to check and treat varices, and imaging to watch for a clot in the portal vein. Because the condition is rare, care at or in contact with a center experienced in vascular liver diseases can help, and anyone with an associated condition will often see other specialists as well.
Ask for an evaluation if you have been told you have an enlarged spleen, unexplained low platelets, or varices but your liver tests are near normal, or if you have been diagnosed with cirrhosis of unknown cause without a biopsy. It is also worth raising with your doctor if you take a medicine linked to this condition, such as a thiopurine, and develop low platelets or an enlarged spleen. Contact your care team promptly if your abdomen swells, your legs swell, your skin or eyes turn yellow, you become unusually confused or sleepy, or you develop new abdominal pain or fever, since these can signal fluid buildup, a portal vein clot or worsening liver function. Vomiting blood, vomit that looks like coffee grounds, or black, tarry stools can mean varices are bleeding. This is an emergency: call 911 or go to an emergency room right away, especially if you also feel lightheaded or faint. Beta-blockers can blunt the usual racing heartbeat that signals heavy blood loss, so do not wait for that sign.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Idiopathic Noncirrhotic Portal Hypertension is like, what's helped you, or ask the community a question.